European Stocks Climb After Weekly Gain as Novartis Rises
This article is for subscribers only.
European advanced, after the biggest weekly gain in more than a month, as investors awaited economic data out of Europe and America later this week.
Novartis AG climbed 3.5 percent after the Swiss drugmaker said the last phase of a clinical trial showed a treatment for chronic heart failure helped patients live longer. Banca Monte dei Paschi di Siena SpA jumped to a 14-month high after its biggest investor said it is selling an additional stake. RWE AG lost 1.3 percent after UBS AG recommended avoiding the stock.